A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.
Van Staa
T P
TP
General Practice Research Database, Medicines and Healthcare Products Regulatory Agency, London, UK. g.y.h.lip@bham.ac.uk
Setakis
E
E
Di Tanna
G L
GL
Lane
D A
DA
Lip
G Y H
GY
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D015331:Cohort Studies; D019992:Databases as Topic; D005260:Female; D058006:General Practice / Q000706:statistics & numerical data; D006305:Health Status Indicators; D006760:Hospitalization; D006801:Humans; D053208:Kaplan-Meier Estimate; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D016016:Proportional Hazards Models; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D014859:Warfarin / Q000627:therapeutic use; D055815:Young Adult
D000925:Anticoagulants; D014859:Warfarin